ELIGARD
Google image searchProduct monograph
Active ingredient
leuprolide acetate, 7.5 MG/SYR
DIN: 02248239
Dosage form(s): POWDER FOR SUSPENSION, SUSTAINED-RELEASE
Route(s) of administration: SUBCUTANEOUS
Description: PREFILLED SYRINGES (1-MONTH) - SINGLE DOSE
Schedule: Prescription
Company: TOLMAR INTERNATIONAL LTD.
Date: 30-MAY-2022
ATC:
- L02 — ENDOCRINE THERAPY (ATC, ATC/DDD, )
- L02A — HORMONES AND RELATED AGENTS (ATC, ATC/DDD)
- L02AE — Gonadotropin releasing hormone analogues (ATC, ATC/DDD)
- L02AE02 — LEUPRORELIN (ATC/DDD)
Reference brand drug: Eligard, Lupron
